Provided by Tiger Trade Technology Pte. Ltd.

PepGen Inc.

5.44
+0.02000.37%
Post-market: 5.440.00000.00%17:42 EST
Volume:581.09K
Turnover:3.13M
Market Cap:373.99M
PE:-1.92
High:5.50
Open:5.42
Low:5.20
Close:5.42
52wk High:6.72
52wk Low:0.8801
Shares:68.75M
Float Shares:45.78M
Volume Ratio:0.75
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8262
EPS(LYR):-2.8490
ROE:-62.25%
ROA:-34.09%
PB:2.29
PE(LYR):-1.91

Loading ...

PepGen Inc. Files Initial Statement of Beneficial Ownership for Chief Business & Legal Officer Joseph Vittiglio

Reuters
·
Dec 11

PepGen Grants Stock Options to New Chief Business and Legal Officer

Reuters
·
Dec 09

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) to Newly Appointed Chief Business and Legal Officer

THOMSON REUTERS
·
Dec 09

BRIEF-PepGen Appoints Joseph Vittiglio, Esq., As Chief Business And Legal Officer

Reuters
·
Dec 08

PepGen Names Joseph Vittiglio Chief Business and Legal Officer

Reuters
·
Dec 08

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

THOMSON REUTERS
·
Dec 08

PepGen Inc. (PEPG) Gets a Sell from Bank of America Securities

TIPRANKS
·
Nov 16

Wedbush Raises Price Target on PepGen to $9 From $8, Keeps Outperform Rating

MT Newswires Live
·
Nov 13

PepGen price target raised to $20 from $18 at H.C. Wainwright

TIPRANKS
·
Nov 13

PepGen Inc. Strengthens Financial Position Amid Ongoing Losses

TIPRANKS
·
Nov 13

PepGen Receives US Patent for Investigational Candidate for Severe Neuromuscular Disease Treatment

MT Newswires Live
·
Nov 12

PepGen announces issuance of patent for PGN-EDODM1

TIPRANKS
·
Nov 12

PepGen Inc - Patent Provides Exclusivity for Pgn-Edodm1 in U.S. Until 2042

THOMSON REUTERS
·
Nov 12

PepGen Q3 EPS $(0.52) Beats $(0.59) Estimate

Benzinga
·
Nov 12

Biotech firm PepGen's Q3 net loss narrows to $18 mln

Reuters
·
Nov 12

PepGen Inc. Granted U.S. Patent for Proprietary PGN-EDODM1 Molecule, Extending Exclusivity Into 2042

Reuters
·
Nov 12

BRIEF-PepGen Q3 EPS USD -0.52

Reuters
·
Nov 12

PepGen reports third quarter net loss of $18.0 million

Reuters
·
Nov 12

PepGen Q3 Operating Expenses USD 18.654 Million

THOMSON REUTERS
·
Nov 12

Press Release: PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Dow Jones
·
Nov 12